Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-NODAGA-E(c[RGDyK])2 PET Imaging
NCT02970786Phase 1Unknown
- Sponsor
- Rigshospitalet
- Start
- Nov 2016
- Primary completion
- Jun 2017
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Rigshospitalet. Primary endpoints: Biodistribution of 68Ga-NODAGA-E(c[RGDyK])2 at 2 hours, Dosimetry of 68Ga-NODAGA-E(c[RGDyK])2 at 2 hours and 1 more. Status: unknown.
Beyond the preview
Go deeper on NCT02970786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02970786.